扆雪涛,于德志,方选,等.抗阿尔茨海默症海藻天然产物及其药理机制研究进展[J].中国海洋药物,2020,39(2):93-100. |
抗阿尔茨海默症海藻天然产物及其药理机制研究进展 |
Research progress of the marine algae-derived compounds with anti-Alzheimer’s potentialYi xuetao,Yu dezhi,Fang xuan,Zhang qi(Qingdao Institute for Food and Drug Control, Qingdao 266000) |
投稿时间:2019-10-15 修订日期:2019-11-04 |
DOI: |
中文关键词: 阿尔茨海默症 海藻天然产物 AD发病机制假说 神经保护 研究进展 |
English Keywords:Alzheimer |
Fund Project: |
|
摘要点击次数: 5306 |
全文下载次数: 862 |
中文摘要: |
阿尔茨海默症(AD)是老年人群发病率最高的神经退性疾病,主要以语言、学习、记忆等认知功能受损及人格改变为特征,目前还没有治疗AD的特效药物,给社会带来的经济和健康问题日益突出。AD的发病机制十分复杂,普遍认为有β淀粉样蛋白沉积假说、tau蛋白假说、神经炎性损伤假说、胆碱能缺失假说和氧化应激假说等多种机制。海洋蕴藏着大量的藻类生物,研究表明来源于海藻的天然产物具有神经保护作用,具有开发成为治疗AD药物的潜力。我国自主研发的昆布来源的甘露寡糖二酸GV971已进入抗AD临床III期实验,为AD患者带来了新希望。本文从AD不同发病机制假说角度综述具有抗AD潜力海藻来源的天然产物及其作用机理,为抗AD海藻药物开发提供参考。 |
English Summary: |
Alzheimer"s disease (AD) is the most common neurodegenerative disease in the elderly. It is characterized by impaired cognitive function such as language, learning, and memory and personality changes. Currently, there is no specific drug for AD. The economic and health problems brought about by this have become increasingly prominent. The pathogenesis of AD is very complicated. It is generally believed that there are many mechanisms such as β amyloid deposition theory, tau protein theory, neuroinflammatory injury theory, cholinergic loss theory and oxidative stress. The sea contains a large number of algae plants. Studies have shown that the natural products derived from algae have neuroprotective effects and have the potential to develope into a drug for AD. The algae-derived mannooligosaccharide GV971, which has been independently developed in China, has entered the phase III trial of anti-Alzheimer’s clinical trials. This brings new hope to AD patients. In this paper, we review the natural products from algae with anti-AD potential and their mechanism of action from the perspective of different pathogenesis hypotheses of AD, and provide reference for the development of anti-AD seaweed drugs. |
查看全文 查看/发表评论 下载PDF阅读器 |
|
关闭 |
|
|
|